These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26866271)

  • 21. BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.
    Gabellini C; De Luca T; Trisciuoglio D; Desideri M; Di Martile M; Passeri D; Candiloro A; Biffoni M; Rizzo MG; Orlandi A; Del Bufalo D
    Carcinogenesis; 2013 Nov; 34(11):2558-67. PubMed ID: 23836782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-2 family interactome analysis using bacterial surface display.
    Zhang S; Link AJ
    Integr Biol (Camb); 2011 Aug; 3(8):823-31. PubMed ID: 21713285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of Bcl-2 expression by HuR in HL60 leukemia cells and A431 carcinoma cells.
    Ishimaru D; Ramalingam S; Sengupta TK; Bandyopadhyay S; Dellis S; Tholanikunnel BG; Fernandes DJ; Spicer EK
    Mol Cancer Res; 2009 Aug; 7(8):1354-66. PubMed ID: 19671677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenazine-1-carboxamide (PCN) from Pseudomonas sp. strain PUP6 selectively induced apoptosis in lung (A549) and breast (MDA MB-231) cancer cells by inhibition of antiapoptotic Bcl-2 family proteins.
    Kennedy RK; Veena V; Naik PR; Lakshmi P; Krishna R; Sudharani S; Sakthivel N
    Apoptosis; 2015 Jun; 20(6):858-68. PubMed ID: 25820140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.
    Yang MC; Loh JK; Li YY; Huang WS; Chou CH; Cheng JT; Wang YT; Lieu AS; Howng SL; Hong YR; Chou AK
    Int J Oncol; 2015 Mar; 46(3):1304-16. PubMed ID: 25586056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells.
    Villeneuve C; Baricault L; Canelle L; Barboule N; Racca C; Monsarrat B; Magnaldo T; Larminat F
    Mol Biol Cell; 2011 Apr; 22(7):999-1013. PubMed ID: 21289092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular profiles and pathogen-induced transcriptional responses of prawn B cell lymphoma-2 related ovarian killer protein (BOK).
    Chaurasia MK; Palanisamy R; Harikrishnan R; Arasu MV; Al-Dhabi NA; Arockiaraj J
    Fish Shellfish Immunol; 2015 Aug; 45(2):598-607. PubMed ID: 25982403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SLIRP Regulates the Rate of Mitochondrial Protein Synthesis and Protects LRPPRC from Degradation.
    Lagouge M; Mourier A; Lee HJ; Spåhr H; Wai T; Kukat C; Silva Ramos E; Motori E; Busch JD; Siira S; ; Kremmer E; Filipovska A; Larsson NG
    PLoS Genet; 2015 Aug; 11(8):e1005423. PubMed ID: 26247782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2.
    Krishna S; Low IC; Pervaiz S
    Biochem J; 2011 May; 435(3):545-51. PubMed ID: 21486225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis induction by Bcl-2 proteins independent of the BH3 domain.
    Hossini AM; Eberle J
    Biochem Pharmacol; 2008 Dec; 76(11):1612-9. PubMed ID: 18778689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
    Huang DC; Adams JM; Cory S
    EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species.
    Um HD
    Oncotarget; 2016 Feb; 7(5):5193-203. PubMed ID: 26621844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis.
    Chatterjee A; Chattopadhyay D; Chakrabarti G
    Cell Signal; 2015 Feb; 27(2):189-203. PubMed ID: 25435430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The involvement of Bcl-2 in mast cell apoptosis.
    Cohen-Saidon C; Razin E
    Novartis Found Symp; 2005; 271():191-5; discussion 195-9. PubMed ID: 16605136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptotic blocks and chemotherapy resistance: strategies to identify Bcl-2 protein signatures.
    Gul O; Basaga H; Kutuk O
    Brief Funct Genomic Proteomic; 2008 Jan; 7(1):27-34. PubMed ID: 18283052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress.
    Cantara S; Donnini S; Giachetti A; Thorpe PE; Ziche M
    J Vasc Res; 2004; 41(2):202-7. PubMed ID: 15031604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2.
    Subramaniam D; Natarajan G; Ramalingam S; Ramachandran I; May R; Queimado L; Houchen CW; Anant S
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1025-32. PubMed ID: 18292181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autophagy capacity and sub-mitochondrial heterogeneity shape Bnip3-induced mitophagy regulation of apoptosis.
    Choe SC; Hamacher-Brady A; Brady NR
    Cell Commun Signal; 2015 Aug; 13():37. PubMed ID: 26253153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.
    Tomek M; Akiyama T; Dass CR
    J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2.
    Lavik AR; Zhong F; Chang MJ; Greenberg E; Choudhary Y; Smith MR; McColl KS; Pink J; Reu FJ; Matsuyama S; Distelhorst CW
    Oncotarget; 2015 Sep; 6(29):27388-402. PubMed ID: 26317541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.